Invention Application
WO2015155323A1 BR2 ANTAGONIST FOR USE IN THE PREVENTION OF THE HYPOTENSIVE EFFECT OF PATIENT TREATED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEI) 审中-公开
BR2拮抗剂用于预防用抗生素转化酶抑制剂(ACEI)治疗患者的高血压效应

BR2 ANTAGONIST FOR USE IN THE PREVENTION OF THE HYPOTENSIVE EFFECT OF PATIENT TREATED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEI)
Abstract:
The present invention relates to a method of preventing and/or treating the hypotensive effect of angiotensin-converting enzyme inhibitors (ACEl) in a patient treated with ACEl, said patient being under a critical condition. More specifically, it concerns the use of a Bradykinin 2 receptor (BR2) antagonist for the prevention and treatment of the hypotensive effect of ACEl in a patient treated with ACEl undergoing emergency anaesthesia or shock resuscitation like hypovolemic shock (i.e. hemorrhagic shock (HS), or vasoplegic shock (i.e. septic shock).
Patent Agency Ranking
0/0